Ovo Labs

To add a bio or update company history, please click update information.

News from Ovo Labs

Ovo Labs raises £4m seed round led by Creator Fund and LocalGlobe to improve fertility outcomes for women over 35

24 Apr 2025

Ovo Labs raises £4m seed round led by Creator Fund and LocalGlobe to improve fertility outcomes for women over 35

Ovo Labs develops fertility therapeutics designed to improve egg quality, aiming to increase IVF success rates for women over 35 by reducing genetic errors that limit viable embryos.

Ovo Labs

Life Sciences
London, United Kingdom
£4m
ovo-labs.com
Update Information

More venture news

Healome Therapeutics
7 Jul 2026
Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences
Revolver Therapeutics
6 Jul 2026
Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
EquityLife Sciences
RQ Bio
25 Jun 2026
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences

Ovo Labs

News from Ovo Labs

Ovo Labs raises £4m seed round led by Creator Fund and LocalGlobe to improve fertility outcomes for women over 35

More venture news

Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease

Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins

RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza